JP2012514992A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012514992A5 JP2012514992A5 JP2011545778A JP2011545778A JP2012514992A5 JP 2012514992 A5 JP2012514992 A5 JP 2012514992A5 JP 2011545778 A JP2011545778 A JP 2011545778A JP 2011545778 A JP2011545778 A JP 2011545778A JP 2012514992 A5 JP2012514992 A5 JP 2012514992A5
- Authority
- JP
- Japan
- Prior art keywords
- channel
- drug
- peptide
- nucleic acid
- channels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR09/00174 | 2009-01-15 | ||
| FR0900174A FR2940973B1 (fr) | 2009-01-15 | 2009-01-15 | Identification de nouvelles toxines antagonistes de canaux calcique type-t a visee analgesique |
| PCT/FR2010/000037 WO2010081971A1 (fr) | 2009-01-15 | 2010-01-15 | Identification de nouvelles toxines antagonistes de canaux calciques type-t a visee analgesique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012514992A JP2012514992A (ja) | 2012-07-05 |
| JP2012514992A5 true JP2012514992A5 (enExample) | 2013-02-07 |
| JP5519702B2 JP5519702B2 (ja) | 2014-06-11 |
Family
ID=40834515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011545778A Active JP5519702B2 (ja) | 2009-01-15 | 2010-01-15 | 鎮痛を目的とする、ｔ型カルシウムチャンネルの新規拮抗薬である毒素の同定 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8664179B2 (enExample) |
| EP (1) | EP2387581B1 (enExample) |
| JP (1) | JP5519702B2 (enExample) |
| CA (1) | CA2749824C (enExample) |
| ES (1) | ES2524564T3 (enExample) |
| FR (1) | FR2940973B1 (enExample) |
| WO (1) | WO2010081971A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014045126A2 (en) * | 2012-09-18 | 2014-03-27 | Uti Limited Partnership | Treatment of pain by inhibition of usp5 de-ubiquitinase |
| US20220089663A1 (en) * | 2019-01-18 | 2022-03-24 | Memorial Sloan Kettering Cancer Center | PROTEINS AND FLUOROPHORE-CONTAINING COMPOUNDS SELECTIVE FOR NaV1.7 |
| US20230241259A1 (en) * | 2020-06-10 | 2023-08-03 | Memorial Sloan Kettering Cancer Center | IMAGING COMPOUNDS SELECTIVE FOR NaV1.7 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776896A (en) * | 1996-01-03 | 1998-07-07 | Zeneca Limited | Analgesic peptides from venom of grammostola spatulata and use thereof |
| US5756663A (en) * | 1996-01-03 | 1998-05-26 | Zeneca Limited | Antiarrhythmic peptide from venom of spider Grammostola spatulata |
| AU6109698A (en) | 1998-02-20 | 1999-09-06 | Zeneca Limited | Analgesic peptides from venom of (grammostola spatulata) and use thereof |
-
2009
- 2009-01-15 FR FR0900174A patent/FR2940973B1/fr not_active Expired - Fee Related
-
2010
- 2010-01-15 ES ES10703318.5T patent/ES2524564T3/es active Active
- 2010-01-15 CA CA2749824A patent/CA2749824C/fr not_active Expired - Fee Related
- 2010-01-15 WO PCT/FR2010/000037 patent/WO2010081971A1/fr not_active Ceased
- 2010-01-15 JP JP2011545778A patent/JP5519702B2/ja active Active
- 2010-01-15 US US13/144,734 patent/US8664179B2/en not_active Expired - Fee Related
- 2010-01-15 EP EP10703318.5A patent/EP2387581B1/fr not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102248165B1 (ko) | N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도 | |
| JP2018530530A5 (enExample) | ||
| CY1119880T1 (el) | Παραγωγα πυρρολοπυριμιδινης για χρηση στη θεραπεια ιικων λοιμωξεων | |
| CY1120685T1 (el) | Ρετινοειδες-λιποσωματα για ενισχυση ρυθμισης εκφρασης hsp47 | |
| JP2012505657A5 (enExample) | ||
| JP2017537611A5 (enExample) | ||
| HRP20200042T1 (hr) | Suprotne nukleinske kiseline za uporabu u liječenju duchennove mišićne distrofije | |
| WO2017053431A3 (en) | Allele selective gene editing and uses thereof | |
| JP2017505623A5 (enExample) | ||
| IL231460B (en) | 5 - methoxy, ho - '3, unblocked nucleotides that undergo rapid degradation by light and methods for nucleic acid sequencing | |
| EP4632075A3 (en) | Method for reducing immunogenicity of rna | |
| JP2015522264A5 (enExample) | ||
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| MX2013009191A (es) | Oligonucleotidos antisentido. | |
| EP4372091A3 (en) | Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides | |
| MY145369A (en) | Multimer for immunostimulation | |
| JP2011522839A5 (enExample) | ||
| JP2011152135A5 (enExample) | ||
| JP2015510393A5 (enExample) | ||
| WO2011142798A3 (en) | Methods of preparing targeted aptamer prodrugs | |
| JP2015533791A5 (enExample) | ||
| JP2013537404A5 (enExample) | ||
| WO2013181404A3 (en) | COMPOSITIONS AND METHODS FOR PEPTIDE EXPRESSION AND PURIFICATION USING A TYPE lll SECRETION SYSTEM | |
| JP2016518838A5 (enExample) | ||
| JP2019505567A5 (enExample) |